Crosstalk between ER stress and immunogenic cell death

Cytokine and Growth Factor Reviews

Volumn 24, Issue 4, 2013, Pages 311-318

  Kepp, Oliver ^a,b,c   Menger, Laurie ^a,b,c   Vacchelli, Erika ^a,b,c   Locher, Clara ^b,c   Adjemian, Sandy ^a,b,c   Yamazaki, Takahiro ^b,c   Martins, Isabelle ^a,b,c   Sukkurwala, Abdul Qader ^a,b,c   Michaud, Michael ^a,b,c   Senovilla, Laura ^a,b,c   Galluzzi, Lorenzo ^c,d   Kroemer, Guido ^c,d,e,f,g   Zitvogel, Laurence ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSERM   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CENTRE DE RECHERCHE DES CORDELIERS   (France)

^f HÔpital Européen Georges Pompidou   (France)

^g University Paris XI   (France)

Author keywords

Anthracyclines; Apoptosis; ATP; Calcium; Calreticulin; PERK

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CALCIUM ION;

APOPTOSIS; ARTICLE; AUTOPHAGY; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL ASSAY; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CELL TYPE; ENDOPLASMIC RETICULUM STRESS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

ANTHRACYCLINES; APOPTOSIS; ATP; CALCIUM; CALRETICULIN; PERK;

ANIMALS; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CELL DEATH; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMANS; MICE; NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 84883747524     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2013.05.001     Document Type: Article

References (75)

1. Casares N., Pequignot M.O., Tesniere A., Ghiringhelli F., Roux S., Chaput N., et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. Journal of Experimental Medicine 2005, 202:1691-1701.
2. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.L., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nature Medicine 2007, 13:54-61.
3. Schiavoni G., Sistigu A., Valentini M., Mattei F., Sestili P., Spadaro F., et al. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis. Cancer Research 2011, 71:768-778.
4. Senovilla L., Vitale I., Martins I., Tailler M., Pailleret C., Michaud M., et al. An immunosurveillance mechanism controls cancer cell ploidy. Science 2012, 337:1678-1684.
5. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine 2007, 13:1050-1059.
6. Ghiringhelli F., Apetoh L., Tesniere A., Aymeric L., Ma Y., Ortiz C., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nature Medicine 2009, 15:1170-1178.
7. Kroemer G., Galluzzi L., Kepp O., Zitvogel L. Immunogenic cell death in cancer therapy. Annual Review of Immunology 2013, 31:51-72.
8. Hannani D., Sistigu A., Kepp O., Galluzzi L., Kroemer G., Zitvogel L. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer Journal 2011, 17:351-358.
9. Kepp O., Galluzzi L., Martins I., Schlemmer F., Adjemian S., Michaud M., et al. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Reviews 2011, 30:61-69.
10. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death and Differentiation 2012, 19:107-120.
11. Garg A.D., Krysko D.V., Verfaillie T., Kaczmarek A., Ferreira G.B., Marysael T., et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO Journal 2012, 31:1062-1079.
12. Zitvogel L., Kepp O., Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010, 140:798-804.
13. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005, 123:321-334.
14. Michaud M., Martins I., Sukkurwala A.Q., Adjemian S., Ma Y., Pellegatti P., et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011, 334:1573-1577.
15. Garg A.D., Krysko D.V., Vandenabeele P., Agostinis P. The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 2012, 1:786-788.
16. Dong Xda E., Ito N., Lotze M.T., Demarco R.A., Popovic P., Shand S.H., et al. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. Journal of Immunotherapy 2007, 30:596-606.
17. Bianchi M.E., Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunological Reviews 2007, 220:35-46.
18. Galluzzi L., Kepp O., Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO Journal 2012, 31:1055-1057.
19. Chao M.P., Jaiswal S., Weissman-Tsukamoto R., Alizadeh A.A., Gentles A.J., Volkmer J., et al. Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Science Translational Medicine 2010, 2(63). ra94.
20. Martins I., Tesniere A., Kepp O., Michaud M., Schlemmer F., Senovilla L., et al. Chemotherapy induces ATP release from tumor cells. Cell Cycle 2009, 8:3723-3728.
21. Zitvogel L., Kepp O., Galluzzi L., Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nature Immunology 2012, 13:343-351.
22. Tschopp J., Schroder K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?. Nature Reviews Immunology 2010, 10:210-215.
23. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejero M., Lichtenberger G.S., Grant E.P., et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006, 24:317-327.
24. Ma Y., Aymeric L., Locher C., Mattarollo S.R., Delahaye N.F., Pereira P., et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. Journal of Experimental Medicine 2011, 208:491-503.
25. Mattarollo S.R., Loi S., Duret H., Ma Y., Zitvogel L., Smyth M.J. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. Cancer Research 2011, 71:4809-4820.
26. Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. Journal of Experimental Medicine 2005, 201:1135-1143.
27. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122.
28. Majeti R., Chao M.P., Alizadeh A.A., Pang W.W., Jaiswal S., Gibbs K.D., et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009, 138:286-299.
29. Chao M.P., Alizadeh A.A., Tang C., Myklebust J.H., Varghese B., Gill S., et al. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell 2010, 142:699-713.
30. Zitvogel L., Kepp O., Kroemer G. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nature Reviews Clinical Oncology 2011, 8:151-160.
31. Panaretakis T., Joza N., Modjtahedi N., Tesniere A., Vitale I., Durchschlag M., et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death and Differentiation 2008, 15:1499-1509.
32. Panaretakis T., Kepp O., Brockmeier U., Tesniere A., Bjorklund A.C., Chapman D.C., et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO Journal 2009, 28:578-590.
33. Kepp O., Galluzzi L., Giordanetto F., Tesniere A., Vitale I., Martins I., et al. Disruption of the PP1/GADD34 complex induces calreticulin exposure. Cell Cycle 2009, 8:3971-3977.
34. Tufi R., Panaretakis T., Bianchi K., Criollo A., Fazi B., Di Sano F., et al. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death and Differentiation 2008, 15:274-282.
35. Kepp O., Senovilla L., Galluzzi L., Panaretakis T., Tesniere A., Schlemmer F., et al. Viral subversion of immunogenic cell death. Cell Cycle 2009, 8:860-869.
36. Galluzzi L., Kepp O., Morselli E., Vitale I., Senovilla L., Pinti M., et al. Viral strategies for the evasion of immunogenic cell death. Journal of Internal Medicine 2010, 267:526-542.
37. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nature Cell Biology 2000, 2:326-332.
38. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397:271-274.
39. Brewer J.W., Diehl J.A. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:12625-12630.
40. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiological Reviews 2007, 87:99-163.
41. Tait S.W., Green D.R. Mitochondria and cell death: outer membrane permeabilization and beyond. Nature Reviews Molecular Cell Biology 2010, 11:621-632.
42. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730.
43. Ng F.W., Nguyen M., Kwan T., Branton P.E., Nicholson D.W., Cromlish J.A., et al. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. Journal of Cell Biology 1997, 139:327-338.
44. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Alyonycheva T.N., Safier L.B., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. Journal of Clinical Investigation 1997, 99:1351-1360.
45. Stagg J., Smyth M.J. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010, 29:5346-5358.
46. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
47. Tesniere A., Schlemmer F., Boige V., Kepp O., Martins I., Ghiringhelli F., et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 2010, 29:482-491.
48. Martins I., Kepp O., Schlemmer F., Adjemian S., Tailler M., Shen S., et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene 2011, 30:1147-1158.
49. Menger L., Vacchelli E., Adjemian S., Martins I., Ma Y., Shen S., et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Science Translational Medicine 2012, 4(143):ra99.
50. Spisek R., Charalambous A., Mazumder A., Vesole D.H., Jagannath S., Dhodapkar M.V. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood 2007, 109:4839-4845.
51. Gonlubol F., Siegel A., Bing R.J. Effect of a cardiac glycoside (cedilanid) on the sodium and potassium balance of the human heart. Circulation Research 1956, 4:298-301.
52. Repke K., Portius H.J. On the identity of the ion-pumping-atpase in the cell membrane of the myocardium with a digitalis receptor enzyme. Experientia 1963, 19:452-458.
53. Perne A., Muellner M.K., Steinrueck M., Craig-Mueller N., Mayerhofer J., Schwarzinger I., et al. Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis. PLoS ONE 2009, 4:e8292.
54. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nature Reviews Molecular Cell Biology 2012, 13:89-102.
55. Ma Y., Hendershot L.M. The mammalian endoplasmic reticulum as a sensor for cellular stress. Cell Stress & Chaperones 2002, 7:222-229.
56. Wang X.Z., Harding H.P., Zhang Y., Jolicoeur E.M., Kuroda M., Ron D. Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO Journal 1998, 17:5708-5717.
57. Harding H.P., Zhang Y., Bertolotti A., Zeng H., Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Molecular Cell 2000, 5:897-904.
58. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287:664-666.
59. Hampton R.Y. ER stress response: getting the UPR hand on misfolded proteins. Current Biology 2000, 10:R518-R521.
60. Kozutsumi Y., Segal M., Normington K., Gething M.J., Sambrook J. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988, 332:462-464.
61. Ron D., Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews Molecular Cell Biology 2007, 8:519-529.
62. Hetz C., Martinon F., Rodriguez D., Glimcher L.H. The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiological Reviews 2011, 91:1219-1243.
63. Yoshida H. Unconventional splicing of XBP-1 mRNA in the unfolded protein response. Antioxidants & Redox Signaling 2007, 9:2323-2333.
64. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology 2006, 26:9220-9231.
65. Green D.R., Galluzzi L., Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011, 333:1109-1112.
66. Ellgaard L., Helenius A. Quality control in the endoplasmic reticulum. Nature Reviews Molecular Cell Biology 2003, 4:181-191.
67. Peters L.R., Raghavan M. Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells. Journal of Immunology 2011, 187:919-931.
68. Booth C., Koch G.L. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell 1989, 59:729-737.
69. Rao R.V., Ellerby H.M., Bredesen D.E. Coupling endoplasmic reticulum stress to the cell death program. Cell Death and Differentiation 2004, 11:372-380.
70. Ferri K.F., Kroemer G. Control of apoptotic DNA degradation. Nature Cell Biology 2000, 2:E63-E64.
71. Denmeade S.R., Mhaka A.M., Rosen D.M., Brennen W.N., Dalrymple S., Dach I., et al. Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy. Science Translational Medicine 2012, 4(140):ra86.
72. Suh D.H., Kim M.K., Kim H.S., Chung H.H., Song Y.S. Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Annals of the New York Academy of Sciences 2012, 1271:20-32.
73. Verfaillie T., Rubio N., Garg A.D., Bultynck G., Rizzuto R., Decuypere J.P., et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death and Differentiation 2012, 19:1880-1891.
74. Hayashi T., Rizzuto R., Hajnoczky G., Su T.P. M.A.M. more than just a housekeeper. Trends in Cell Biology 2009, 19:81-88.
75. Giorgi C., Ito K., Lin H.K., Santangelo C., Wieckowski M.R., Lebiedzinska M., et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.